Magnetar Financial LLC Novartis Ag Transaction History

Magnetar Financial LLC

$3.44 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$92.57 - $107.37 $55.6 Million - $64.5 Million	-600,600 Reduced 31.51%	1,305,446 $139 Million
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $63.5 Million - $72.3 Million	666,104 Added 53.72%	1,906,046 $184 Million
Q4 2023 Feb 13, 2024	BUY	$92.27 - $101.54 $40.6 Million - $44.7 Million	440,244 Added 55.05%	1,239,942 $125 Million
Q3 2023 Nov 14, 2023	BUY	$94.73 - $105.13 $44.5 Million - $49.4 Million	469,986 Added 142.54%	799,698 $81.5 Million
Q2 2023 Aug 11, 2023	BUY	$92.52 - $104.91 $30.5 Million - $34.6 Million	329,712 New	329,712 $33.3 Million
Q1 2021 May 14, 2021	SELL	$83.5 - $98.47 $13.5 Million - $15.9 Million	-161,379 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $4.82 Million - $5.83 Million	-61,777 Reduced 27.68%	161,379 $15.2 Million
Q3 2020 Nov 16, 2020	BUY	$82.14 - $91.0 $12.5 Million - $13.8 Million	152,036 Added 213.77%	223,156 $19.4 Million
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $5.76 Million - $6.48 Million	71,120 New	71,120 $6.21 Million
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $14.9 Million - $20.8 Million	-210,182 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$84.35 - $95.37 $13.2 Million - $14.9 Million	156,182 Added 289.23%	210,182 $19.9 Million
Q3 2019 Nov 14, 2019	BUY	$85.54 - $94.26 $342,160 - $377,040	4,000 Added 8.0%	54,000 $4.69 Million
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $377,000 - $464,000	5,000 Added 11.11%	50,000 $4.57 Million
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $3.39 Million - $3.88 Million	45,000 New	45,000 $4.33 Million

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnetar Financial LLC with notifications on news.

Account